BE694496A - - Google Patents

Info

Publication number
BE694496A
BE694496A BE694496DA BE694496A BE 694496 A BE694496 A BE 694496A BE 694496D A BE694496D A BE 694496DA BE 694496 A BE694496 A BE 694496A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE694496A publication Critical patent/BE694496A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE694496D 1966-02-23 1967-02-23 BE694496A (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8043/66A GB1180233A (en) 1966-02-23 1966-02-23 Modified Spiramycin

Publications (1)

Publication Number Publication Date
BE694496A true BE694496A (cs) 1967-07-31

Family

ID=9844680

Family Applications (1)

Application Number Title Priority Date Filing Date
BE694496D BE694496A (cs) 1966-02-23 1967-02-23

Country Status (5)

Country Link
BE (1) BE694496A (cs)
DE (1) DE1593741A1 (cs)
GB (1) GB1180233A (cs)
LU (1) LU53049A1 (cs)
NL (1) NL6702425A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it

Also Published As

Publication number Publication date
LU53049A1 (cs) 1967-06-16
NL6702425A (cs) 1967-08-24
GB1180233A (en) 1970-02-04
DE1593741A1 (de) 1970-09-03

Similar Documents

Publication Publication Date Title
AT281852B (cs)
AU5917865A (cs)
AU424443B2 (cs)
AU428063B2 (cs)
AU421822B2 (cs)
AU415165B1 (cs)
AU414526B2 (cs)
AU417216B2 (cs)
AU433222B2 (cs)
AU218666A (cs)
AU5895065A (cs)
AU1144366A (cs)
AU1111066A (cs)
AU612166A (cs)
AU6703465A (cs)
BE694125A (cs)
AU855865A (cs)
AU414093B2 (cs)
AU411645B2 (cs)
AU407778B2 (cs)
BE694734A (cs)
BE692843A (cs)
AU433620A (cs)
AU2390066A (cs)
AU1027866A (cs)